Interestingly, higher plasma transferrin levels in AD patients have been reported to be associated with more rapid cognitive decline, but the reasons for this remain unclear.[62] Since this is the first report of TFRE dysregulation in human AD neurons, this finding may have both pathogenic and therapeutic implications. This evidence concerns the gene TF and Alzheimer disease.